Factor V Leiden can affect the use of hormonal contraceptives, particularly those containing estrogen. These contraceptives may increase clotting risk. Women with the mutation should discuss contraceptive options with their healthcare providers, who may recommend alternative methods or lower-dose estrogen options to minimize the risk of blood clots.